Gunilla Petersson is Science & Innovation Director, Inhaled Drug Delivery, at AstraZeneca, affiliated to the Innovation Strategies & Internal Liaison (IS&EL) segment. Dr Petersson holds a PhD in Analytical Chemistry from Lund University (Sweden). She has been at AstraZeneca for 25 years, holding different line management and scientific expert roles linking formulations and devices, mainly for inhaled drug product development, having worked in technology development and scouting, product development and registrations of new products, competitor landscape, CMC industry consortia boards and working teams (EPAG, IPAC-RS) for 10 years, drug project due diligences and scientific marketing of AstraZeneca products.


W3 Total Cache is currently running in Pro version Development mode.